Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders - Tập 26 Số 6 - Trang 522-527 - 2008
Nicolaas A. Verwey1, Alie Schuitemaker1, Wiesje M. van der Flier1, Sandra D. Mulder2, Cees Mulder2, C. Erik Hack2, Philip Scheltens1, Marinus A. Blankenstein2, Robert Veerhuis2
1Neurology,
2Clinical Chemistry

Tóm tắt

<i>Background:</i> Serum amyloid P component (SAP), present in amyloid-β (Aβ) plaques in Alzheimer’s disease (AD), may protect Aβ deposits against proteolysis, thereby promoting plaque formation. The aim was to investigate if SAP levels in cerebrospinal fluid (CSF) and serum can be used to discriminate controls, AD and mild cognitive impairment (MCI) patients, and to identify incipient AD among MCI patients. <i>Methods:</i> SAP levels in CSF and serum were determined in 30 controls, 67 MCI and 144 AD patients. At follow-up, 39 MCI patients had progressed to dementia, while 25 had remained stable (mean follow-up time: 2.6 ± 1.0 and 2.1 ± 0.8 years). <i>Results:</i> Cross-sectionally no differences were found in SAP levels in CSF and serum between the groups. MCI patients that had progressed to dementia at follow-up had lower CSF SAP levels (13 mg/l, range 3.3–199.3 mg/l) than MCI nonprogressors (20.2 mg/l, range 7.0–127.7 mg/l; p < 0.05). A low CSF SAP level was associated with a 2-fold increased risk of progression to AD (hazard ratio = 2.2; 95% confidence interval = 0.9–5.4). <i>Conclusion:</i> Our data suggest that measurement of CSF SAP levels can aid in the identification of incipient AD among MCI patients.

Từ khóa


Tài liệu tham khảo

10.1001%2Farchneur.56.3.303

10.1212%2FWNL.34.7.939

10.1212%2F01.wnl.0000238517.59286.c5

10.1097%2F00005072-199409000-00003

10.1016%2F1055-8330%2895%2990018-7

10.1038%2F367338a0

10.1073%2Fpnas.91.12.5602

10.1007%2FBF00868345

10.1006%2Fbbrc.1995.1819

10.1038%2Fnm0897-855

10.1073%2Fpnas.92.10.4299

10.1038%2F417254a

10.1016%2Fj.jns.2007.01.050

10.2174%2F1568007054038184

10.1016%2Fj.neulet.2007.01.052

10.1016%2Fj.brainres.2007.01.132

10.1007%2Fs00702-002-0763-y

10.1159%2F000106889

10.1016%2FS0304-3940%2899%2900631-X

10.1159%2F000017035

10.1006%2Fbbrc.1994.1760

10.1016%2F0022-3956%2875%2990026-6

10.1192%2Fbjp.165.3.324

10.1016%2Fj.jns.2004.09.016

10.1006%2Fbrcg.1996.0041

10.3109%2F13506120009146438

10.1016%2FS0197-4580%2801%2900288-3

Thông tin
Thông tin xuất bản

Dementia and Geriatric Cognitive Disorders

Tập 26 Số 6

522-527

Thông tin tác giả